Published by Josh White on 13th April 2022
(Sharecast News) - Specialist drug discovery and development company ImmuPharma reported positive data from its 'Lupuzor' pharmacokinetic study on Wednesday, as part of the new, optimised international third phase trial in lupus patients.
URL: http://www.digitallook.com/dl/news/story/32605005/...